It appears as if Ian Goddard <Ian@goddard.net> wrote:
|It's amazing to think that as of 1996, 10 to 12 percent
|of schoolboys in the U.S were on an addictive drug, Ritalin,
|about which the manufacture states: "Sufficient data on safety
|and efficacy of long-term use of Ritalin in children are not yet
|available. ... Long-term effects of Ritalin in children have not
|been well established." (1998) While the statements are an effort
|to avoid liability for any harm caused by their product, they're
|also largely true: after being on the market for decades, there
|are few if any long-term studies on Ritalin use. But there are
|some clues. The manufacture's insert also notes that growth
|suppression has been reported. Some research suggests
|the possibility of brain atrophy after chronic use.
In the olden days a drug called ``Ritalina'' existed which contained
amphetamines. Would the ``Ritalin'' be identical to ``Ritalina''?
The manufacturer made ``Ritalina'' for people who wanted to lose weight.
As some doctors order amphetamines for young humans diagnosed with DAMP,
the above identity hypothesis seems to hold its water, as it were.
As some doctors order amphetamines for young humans diagnosed with DAMP, the above identity hypothesis seems to hold its water, as it were.